Former Chairman of Sunflower Pharmaceutical Co. suspected of intentional homicide: the fastest afternoon notice

category:Society click:13
 Former Chairman of Sunflower Pharmaceutical Co. suspected of intentional homicide: the fastest afternoon notice


On the morning of April 10, Pengmei News reported that several authoritative sources confirmed that Guan Yanbin, the former chairman of Sunflower Pharmaceutical Industry, was arrested on suspicion of intentional homicide by the Peoples Procuratorate of Jean-Hu Road District in Daqing City, and the arrest time was January 29 by the public security organs. The case is still under investigation.

Sunflower Pharmaceutical shares plunged on April 10, touching a halt. By the end of the afternoon, the companys share price fell 5.27% to 18.17 yuan per share. China Securities News reporters learned from people familiar with the matter that Guan Yanbin, the former chairman of Sunflower Pharmaceutical Industry, was involved in the case or related to property division, according to China Securities Network. According to the Southern Metropolis Daily, the official telephone operator of the Dong Secretariat Office responded that a circular would be sent to respond to the matter quickly and the fastest is this afternoon.

On the afternoon of April 9, Pengmei News sent an interview letter to the designated mailbox of Sunflower Pharmaceutical Industry. The operator said that someone would check the mail and if there is any need, someone would contact you. On the morning of April 10, PengMei News called the office of the Secretary of Sunflower Pharmaceutical Industry. The operator said that the correspondent would be contacted by the Commissioner. Up to the time of publication, the surging news has not been answered.

The company released its annual report in late March, disclosing that Guan Yanbin was taken compulsory measures by the judicial authorities.

On the evening of January 1, 2019, Sunflower Pharmaceutical Industry issued a notice that the board of directors of Sunflower Pharmaceutical Industry received a written resignation report from the chairman and general manager of the company on December 28, 2018. Guan Yanbin applied for resignation as a director, chairman and general manager because of his personal age. From the perspective of long-term development of the company, in order to give young people more opportunities and optimize the management team, and resigned at the same time. Relevant positions of members of the third board of directorsstrategic committee shall only serve as the director of the companys Strategic Advisory committee. The announcement also shows that Guan Yanbins resignation will not lead to the change of the companys actual controller, nor will it affect the normal operation and management of the company.

The aforementioned announcement did not mention Guan Yanbins suspected criminal offence. Then on March 21, Sunflower Pharmaceutical disclosed in its annual report that Guan Yanbin was suspected of breaking the law and committing a crime, but the wording was euphemistic.

The annual report issued by Sunflower Pharmaceutical Industry totals 186 pages. On page 39, it states that Guan Yanbin, the actual controller, caused bodily injury by disputes with others due to personal reasons and was taken compulsory measures by judicial organs. The incident did not affect the normal production and operation activities of listed companies. Its exercise of shareholder rights is not affected.

The company released its annual report in late March, disclosing that Guan Yanbin was taken compulsory measures by the judicial authorities.

Xu Feng, senior partner of Shanghai Chuangyuan Law Firm, said that if the chairman of the board of directors was taken compulsory measures before resignation by the judiciary, listed companies should disclose information in time; if the actual controller of the company was taken compulsory measures by the judiciary, it belongs to the situation of the actual controller controlling the company has changed greatly, that is, although it is nominal actual controller, it can do so. In accordance with the provisions of Article 67 of the Securities Law and the Measures for the Management of Information Disclosure of Listed Companies, it is also necessary to timely submit an interim report on the major event to the securities regulatory authority under the State Council and the stock exchange, and to make a public announcement to explain the causes, current status and possible legal consequences of the event. At the same time, timely refers to two trading days starting from the date of calculation or touching the time of disclosure.

Guan Yanbin is still the actual controller. He divorced his wife after 60 years old.

According to Tian Eye Check, up to now, Guan Yanbin is still the controlling shareholder, actual controller and final controller of sunflower pharmacy industry.

According to the official website of Sunflower Pharmaceutical Industry, Guan Yanbin is the representative of the 11th and 12th National Peoples Congress, the national labor model, the national outstanding socialist builder with Chinese characteristics, the national May Day labor medal winner, the outstanding private entrepreneurs in China, and the top ten leading figures in Chinese pharmaceutical industry from 2014 to 2016.

More than a year ago, 63-year-old Guan Yanbin divorced his wife Zhang Xiaolan, 58. Zhang Xiaolans pure family background has aroused a lot of attention.

On July 12, 2017, Sunflower Pharmaceutical Industry announced that Guan Yanbin and Zhang Xiaolan, the actual controllers of the company, were divorced and the actual controllers of the company were changed to Guan Yanbin. On the day of their divorce, Zhang Xiaolan applied to resign as director and deputy general manager of Sunflower Pharmaceutical Industry for personal reasons.

According to Daily Economic News, the divorced couple did not share their shares equally. According to the three split agreements, Zhang Xiaolans shares, worth 63 million yuan, were transferred to Guan Yanbin. So far, Guan Yanbin directly holds 43.6717 million shares of Sunflower Pharmaceutical Co., Ltd. with a share ratio of 14.96%. He has become the only actual controller of Sunflower Pharmaceutical Co., Ltd. According to the valuation at that time, Guan Yanbins direct and indirect ownership of the stock market after divorce amounted to 3.3 billion yuan.

Source of this article: Peng Mei News Responsible Editor: Li Wan_B11284